Home > Nanotechnology Columns > Bergeson & Campbell, P.C. > UCSF's Program on Reproductive Health and the Environment Publishes Recommendations for Addressing Health Risks from Nanomaterials in California
 |
Lynn L. Bergeson Managing Director Bergeson & Campbell, P.C. |
Abstract:
On May 5, 2011, the University of California, San Francisco's (UCSF) Program on Reproductive Health and the Environment announced the publication of its Recommendations for Addressing Potential Health Risks from Nanomaterials in California, which provides recommendations for addressing potential health risks from nanomaterials to the Office of Environmental Health Hazard Assessment (OEHHA) and to the State of California. OEHHA contracted with UCSF to prepare the report, which provides an overview of nanotechnology materials, potential exposures, and human-health risks, and recommendations for addressing potential health hazards and risks from nanotechnology. Recommendations include those that can be implemented under the existing regulatory structure of OEHHA, such as establishing a publicly accessible clearinghouse and inventory of nanomaterial sources and products.
May 11th, 2011
UCSF's Program on Reproductive Health and the Environment Publishes Recommendations for Addressing Health Risks from Nanomaterials in California
On May 5, 2011, the University of California, San Francisco's (UCSF) Program on Reproductive Health and the Environment announced the publication of its Recommendations for Addressing Potential Health Risks from Nanomaterials in California, which provides recommendations for addressing potential health risks from nanomaterials to the Office of Environmental Health Hazard Assessment (OEHHA) and to the State of California. The report is available at http://prhe.ucsf.edu/prhe/nanodocument.html OEHHA contracted with UCSF to prepare the report, which provides an overview of nanotechnology materials, potential exposures, and human-health risks, and recommendations for addressing potential health hazards and risks from nanotechnology. Recommendations include those that can be implemented under the existing regulatory structure of OEHHA, such as establishing a publicly accessible clearinghouse and inventory of nanomaterial sources and products.
The report also includes recommendations that are outside the scope of OEHHA, many of which may require legislative changes, such as requiring testing of release and exposure potential for nanomaterials in existing and new consumer products, and implementing a labeling system that requires labeling of products that contain nanomaterials. According to UCSF, the recommendations primarily focus on requiring information on potential exposures and health hazards for nanomaterials used in the marketplace.
Recommendations for OEHHA to address health risks from nanomaterials that can be achieved under the existing regulatory structure:
- Develop a definition of nanomaterials that can be used to identify them;
- Identify and define priority properties for risk characterization and collect information about them for each nanomaterial;
- Develop characteristics by which to define, describe, and group nanomaterials according to conventional or unique properties;
- Establish a publicly accessible clearinghouse and inventory of nanomaterial sources and products;
- Identify and/or develop methods for monitoring nanomaterials in environmental media and through human biomonitoring;
- Collect information on the fate and transport of nanomaterials, including through monitoring in environmental and biological media;
- As for other chemicals, focus on identifying and addressing nanomaterials that are persistent, bioaccumulative, and toxic (PBT);
- Use existing hazard traits from other chemicals and toxicological and environmental-health-related endpoints to assess potential adverse health outcomes from nanomaterial exposure;
- Evaluate existing risk-assessment guidelines to determine whether they sufficiently cover nanomaterials, adjusting or incorporating nano-specific approaches as needed;
- Integrate nanomaterials into current efforts to modernize toxicity testing;
- Develop and maintain relationships with other governments and researchers to share relevant data and information on nanotechnology and nanomaterials' use, applications, and toxicity;
- Improve coordination and monitor communication among federal and state agencies, other countries' governments, businesses, and non-governmental organizations; and
- Continue to include opportunities for public input and comment during decision-making processes.
Recommendations to support successful approaches to address potential health risks from nanomaterials that are currently outside the scope of OEHHA:
- Require disclosure of where and what nanomaterials are manufactured, in what quantities, and for what new or existing products;
- Require reporting of properties that can identify nanomaterials that are PBTs. Phase out uses consistent with approaches for other PBTs;
- Develop a framework for making policy and regulatory decisions that balances the uses and benefits of nanomaterials with their toxicity and exposure potential;
- Require testing of release and exposure potential for nanomaterials in consumer products for both existing and new products;
- Increase efforts to protect and educate workers, researchers, and downstream users of nanomaterials;
- Require sufficient toxicological testing -- preferably pre-market and also post-market as necessary -- to assess risks to manufacturing and other workers and to downstream users, including consumers and susceptible subpopulations such as infants;
- Implement a labeling system that requires labeling of products that contain nanomaterials;
- Increase funding and support for targeted, nano-specific research to fill data gaps; and
- Conduct targeted research on the biological fate, transport, and distribution of nanomaterials, including sources, exposure routes, and internal distributions. Integrate this research with information gathered on exposure potential.
Bookmark:
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||